Titan Pharmaceuticals, Inc.
NASDAQ: TTNP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Weei Jye Chay
- Employees
- 4
- Headquarters
- Petaling Jaya, Cayman Islands
- IPO year
- 1996
- Market cap
- $3.1M
- Website
- https://www.titanpharm.com
Loading TTNP…
Loading profile data…Frequently asked questions about TTNP
What does Titan Pharmaceuticals, Inc. (TTNP) do?
Titan Pharmaceuticals, Inc. is a pharmaceutical company dedicated to creating treatments for chronic conditions, with its product development centered around ProNeura, a unique platform designed for extended drug release. Currently, the company markets the Probuphine implant in Canada and the European Union. This implant provides maintenance tre...
Where does TTNP trade?
Titan Pharmaceuticals, Inc. (TTNP) trades on the NASDAQ Capital Market.
What sector is TTNP in?
Titan Pharmaceuticals, Inc. (TTNP) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Titan Pharmaceuticals, Inc.?
Weei Jye Chay is the chief executive officer of Titan Pharmaceuticals, Inc. (TTNP).
Where is Titan Pharmaceuticals, Inc. headquartered?
Titan Pharmaceuticals, Inc. is headquartered in Cayman Islands.
Does TTNP pay a dividend?
Titan Pharmaceuticals, Inc. (TTNP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TTNP go public?
Titan Pharmaceuticals, Inc. (TTNP) completed its initial public offering in 1996.